Evidence map›Paper›PMID 40600982›Full record

ReviewArchives of toxicology2025

Spirulina as a natural shield: a comprehensive review of its protective effects against lead toxicity.

Mohamed Kamel, Sami Aleya, Maxime Louzon, Lotfi Aleya

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed KamelDepartment of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, 11221, Egypt.
Sami AleyaFaculty of Medicine, Université de Bourgogne Franche-Comté, Hauts-du-Chazal, 25030, Besançon, France.
Maxime LouzonEcosystem Department, ENVISOL, 77 Avenue La Bruyère, 38100, Grenoble, France.
Lotfi AleyaLaboratoire de Chrono-Environnement, Université de Bourgogne Franche-Comté, UMR CNRS 6249, La Bouloie, 25030, Besançon, France. lotfi.aleya@univ-fcomte.fr.ORCID 0000-0001-9742-4368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lead toxicity remains a significant global health challenge, causing cancers and profound effects on the neurological, hepatic, cardiovascular, renal, skeletal, reproductive, and hematologic systems. Despite ongoing public health efforts, vulnerable populations, particularly children and those in lead-related occupations, continue to suffer from its impacts. This review article presents Spirulina platensis, a nutrient-rich cyanobacterium, as a promising dietary supplement with potential protective effects against lead toxicity. Spirulina's multifaceted mechanisms of action, including antioxidant properties, heavy metal chelation, anti-inflammatory effects, and immunomodulation, position it as a viable therapeutic option for mitigating lead-induced damage. A comprehensive evaluation of current in vitro and in vivo studies highlights Spirulina's ability to reduce oxidative stress and improve organ function in lead-exposed models. While the potential benefits of Spirulina are evident, challenges, such as variability in product quality and need for standardized protocols, must be addressed. This review emphasizes the importance of further research to explore the long-term effects of Spirulina supplementation and its integration into public health strategies aimed at reducing lead toxicity. Ultimately, Spirulina platensis represents a natural intervention that could enhance detoxification efforts and improve health outcomes for individuals affected by lead exposure.

Indexed as

Dietary SupplementsLeadLead PoisoningSpirulinaAnimalsAnti-Inflammatory AgentsAntioxidantsHumansOxidative StressAnti-Inflammatory AgentsAntioxidantsLeadAntioxidantChelationDetoxificationLead toxicityNeuroprotectionSpirulina

Identifiers

PMID40600982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.